BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

WOLVERINE ASSET MANAGEMENT LLC's Holding History (CIK: 0001279891)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 45,665,000 Value ($000) $86,201 Avg Close — Range —
Q3 2025
Shares 90,165,000 Value ($000) $126,635 Avg Close — Range —
Q2 2025
Shares 90,165,000 Value ($000) $112,802 Avg Close — Range —
Q1 2025
Shares 59,765,000 Value ($000) $68,193 Avg Close — Range —
Q4 2024
Shares 47,903,000 Value ($000) $50,171 Avg Close — Range —
Q3 2024
Shares 26,363,000 Value ($000) $27,235 Avg Close — Range —
Q2 2024
Shares 15,840,000 Value ($000) $15,983 Avg Close — Range —
Q1 2024
Shares 41,390,000 Value ($000) $44,607 Avg Close — Range —
Q4 2023
Shares 14,000,000 Value ($000) $16,891 Avg Close — Range —
Q1 2022
Shares 58,069,000 Value ($000) $33,968 Avg Close — Range —
Q4 2021
Shares 82,696,000 Value ($000) $60,688 Avg Close — Range —
Q3 2021
Shares 82,696,000 Value ($000) $114,303 Avg Close — Range —
Q2 2021
Shares 72,696,000 Value ($000) $119,378 Avg Close — Range —
Q1 2021
Shares 66,696,000 Value ($000) $110,306 Avg Close — Range —